Agilent Technologies, Inc. $A Shares Purchased by Maryland State Retirement & Pension System

Maryland State Retirement & Pension System increased its position in shares of Agilent Technologies, Inc. (NYSE:A) by 3.2% in the second quarter, HoldingsChannel reports. The firm owned 13,849 shares of the medical research company’s stock after acquiring an additional 425 shares during the quarter. Maryland State Retirement & Pension System’s holdings in Agilent Technologies were worth $1,634,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also modified their holdings of the stock. Valeo Financial Advisors LLC raised its position in Agilent Technologies by 3.0% during the first quarter. Valeo Financial Advisors LLC now owns 3,449 shares of the medical research company’s stock valued at $403,000 after acquiring an additional 102 shares in the last quarter. Cary Street Partners Financial LLC increased its stake in shares of Agilent Technologies by 2.9% in the 1st quarter. Cary Street Partners Financial LLC now owns 3,688 shares of the medical research company’s stock valued at $431,000 after purchasing an additional 103 shares in the last quarter. Western Pacific Wealth Management LP increased its stake in shares of Agilent Technologies by 15.2% in the 1st quarter. Western Pacific Wealth Management LP now owns 873 shares of the medical research company’s stock valued at $102,000 after purchasing an additional 115 shares in the last quarter. Bartlett & CO. Wealth Management LLC increased its stake in shares of Agilent Technologies by 5.1% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 2,406 shares of the medical research company’s stock valued at $281,000 after purchasing an additional 116 shares in the last quarter. Finally, Brighton Jones LLC grew its holdings in Agilent Technologies by 2.6% in the first quarter. Brighton Jones LLC now owns 4,784 shares of the medical research company’s stock valued at $560,000 after purchasing an additional 121 shares during the period.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on A shares. Weiss Ratings reiterated a “hold (c)” rating on shares of Agilent Technologies in a report on Wednesday. Barclays increased their price objective on Agilent Technologies from $125.00 to $150.00 and gave the company an “equal weight” rating in a research note on Thursday, October 2nd. Evercore ISI upped their target price on shares of Agilent Technologies from $128.00 to $140.00 and gave the stock an “in-line” rating in a report on Tuesday, October 7th. JPMorgan Chase & Co. boosted their price target on shares of Agilent Technologies from $155.00 to $165.00 and gave the stock an “overweight” rating in a research report on Thursday. Finally, Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Friday, October 3rd. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $148.69.

Agilent Technologies Price Performance

Shares of A stock opened at $136.62 on Friday. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.71. The firm’s 50-day moving average is $125.04 and its two-hundred day moving average is $117.03. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $153.84. The company has a market capitalization of $38.73 billion, a PE ratio of 32.07, a price-to-earnings-growth ratio of 4.46 and a beta of 1.26.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $1.37. The business had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The business’s revenue was up 10.1% compared to the same quarter last year. During the same quarter last year, the firm earned $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th will be paid a $0.248 dividend. This represents a $0.99 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 30th. Agilent Technologies’s dividend payout ratio is 23.24%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.